medigraphic.com

2008, Number 3

<< Back Next >>

Arch Cardiol Mex 2008; 78 (3)

Fibrinolytic therapy in left side-prosthetic valve acute thrombosis. In depth systematic review

Reyes-Cerezo E, Jerjes-Sánchez C, Archondo-Arce T, García-Sosa A, Garza-Ruiz A, Ramírez-Rivera A, Ibarra-Pérez C

Language: English
References: 53
Page: 309-317
PDF size: 108.33 Kb.


ABSTRACT

Background: Limited data are available on the impact and safety of fibrinolytic therapy (FT) in left – side prosthetic valve acute thrombosis (PVAT). Study objective: To improve our knowledge about the FT role in left –side PVAT. Design: Bibliographic search and analysis. Methods: MEDLINE search from January 1970 to January 2007. Studies were classified according to the evidence level recommendations of the American College of Chest Physicians and included if they had objective diagnosis of left-side PAVT and FT efficacy assessment (hemodynamic, echocardiographic or fluoroscopic improvement). New York Heart Association class was used to establish functional state. Data on clinical characteristics, diagnosis strategy, anticoagulation status, fibrinolytic and heparin regimens, cardiovascular adverse events, outcome, and follow-up were also required. Results: A systematic search produced a total of 900 references. Each abstract was analyzed according to the predetermined criteria. Thirty-two references with 904 patients constitute the subject of this analysis. Only one trial had evidence III and thirty-one evidence V. FT was more used in young female patients (64%) with prosthetic mitral valve thrombosis (77%), and clinical instability (82%). Transesophageal echocardiogram had a higher thrombus detection rate (100%). Although several fibrinolytic regimens were used in a first or second course, streptokinase was the most frequent agent (61%). Clinical improvement was observed in 86% of the patients, objective success in 78%, and failure in 14%. Rescue fibrinolysis was done in 17%. Complications: peripheral and cerebral embolism rate was 5% and 4%, respectively. Major bleeding 4% and intracranial hemorrhage 1%. Conclusions: The available evidence demonstrates that in PVAT fibrinolytic therapy improves the outcome in younger, more ill patients, especially females, independently of the fibrinolytic regimen used with a low complications rate.


REFERENCES

  1. Huseybe DG, Pluth JR, Piheler JM: Reoperation on prosthetic heart valves an analysis of risk factors in 552 patients. J Thorac Cardiovasc Surg 1983; 86: 543-552.

  2. Braunwald E, Cannon C, McCabe CH: Use of composite endpoints in thrombolysis trials of acute myocardial infarction. Am J Cardiol 1993; 72: 3G-12G.

  3. Jerjes-Sanchez C, Ramirez-Rivera A, Garcia MM, Arriaga-Nava R, Valencia S, Rosado-Buzzo A, et al: Streptokinase and heparin versus heparin alone in massive pulmonary embolism: A randomized controlled trial. J Thromb Thrombolysis 1995; 2: 227-229.

  4. Jerjes-Sanchez C, Ramirez-Rivera A, Arriaga-Nava R, Iglesias-Gonzalez S, Gutierrez P, Ibarra-Perez C, et al: High dose and short-term streptokinase infusion in patients with pulmonary embolism. Prospective with seven-year follow-up trial. J Thromb Thrombolysis 2001; 12: 237-247.

  5. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587.

  6. Jerjes-Sanchez C, Ramirez-Rivera A, Elizalde GJ, Delgado R, Cicero R, Ibarra-Perez C, et al: Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema. A Multicenter Trial. Chest 1996; 109: 1514-1519.

  7. Cannegieter SC, Rosendaal FR: Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635-641.

  8. Akins CW: Results with mechanical cardiac valvular prostheses. Ann Thorac Surg 1995; 60: 1836-1844.

  9. Baille Y, Choffel J, Sicard MP: Traitement thrombolytique des thromboses de prothese valvulaire (Letter). Nouv Presse Med 1974; 3: 1233.

  10. Lengyel M, Fuster V, Keltai M, Roudaut R, Schulte HD, Seward JB: Guidelines for management of left-side prosthetic valve thrombosis: a role for thrombolytic therapy. J Am Coll Cardiol 1997; 30: 1521-1526.

  11. Bonow RO, Carabello B, de Leon AC: ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. (committee on management of patients with valvular heart disease). J Am Coll Cardiol 1998; 32: 1486-1582.

  12. Özkan M, Kaymaz C, Kirma C, Sönmez K, Özdemir N, Balkanay M, et al: Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography. J Am Coll Cardiol 2000; 35: 1881-1889.

  13. Fourth American College of Chest Physicians consensus conference on antithrombotic therapy. Chest 1992; 102 (Suppl): 1S-549S.

  14. Witchitz S, Veyrat C, Moisson P, Scheinman N, Rozenstajn L: Fibrinolytic treatment of thrombus on prosthetic heart valves. Br Heart J 1980; 44: 545-554.

  15. Ledain LD, Ohayon JP, Colle JP, Lorient-Roudaut FM, Roudaut RP, Besse PM: Acute thrombotic obstruction with disc valve prostheses: Diagnostic considerations and fibrinolytic treatment. J Am Coll Cardiol 1986; 7: 743-751.

  16. Lorient - Roudaut MF, Ledain L, Roudaut R, Besse P, Boisseau MR: Thrombolytic treatment of acute thrombolytic obstruction with disk valve prostheses: Experience with 26 Cases. Semin Thromb Hemost 1987; 13: 201-205.

  17. Zoghbi WA, Desir RM, Rosen L, Lawrie GM, Pratt CM, Quinones MA: Doppler echocardiography: Application to the assessment of successful thrombolysis of prosthetic valve thrombosis. J Am Soc Echo 1989; 2: 98-101.

  18. Wilkinson GAL, Williams WG: Fibrinolytic treatment of acute prosthetic heart valve thrombosis. Five cases and a review. Eur J Cardio-Thorac Surg 1989; 3: 178-183.

  19. Dzavik V, Cohen G, Chan KL: Role of transesophageal echocardiography in the diagnosis and management of prosthetic valve thrombosis. J Am Coll Cardiol 1991; 18: 1829-1833.

  20. Vasan RS, Kaul U, Sanghvi S, Kamlakar T, Prakash N, Shrivastava S, et al: Thrombolytic therapy for prosthetic valve thrombosis: A study based on serial Doppler echocardiographic evaluation. Am Heart J 1992; 123: 1575-1580.

  21. Roudaut R, Labble T, Lorient-Roudaut MF, Gosse P, Baudet E, Fontan F, et al: Mechanical cardiac valve thrombosis. Is fibrinolysis justified? Circulation 1992; 86 (Suppl II): II-8-II-15

  22. Silber H, Khan SS, Matloff JM, Chaux A, DeRobertis M, Gray R: The St. Jude valve: Thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation 1993; 87: 30-37.

  23. Guerrero LF, Vazquez MG, Reina TA, Rodriguez BI, Fernandez ME, Aranegui LP: Thrombolytic treatment for massive thrombosis of prosthetic cardiac valves. Intensive Care Med 1993; 19: 145-150.

  24. Solorio S, Sanchez H, Madrid R, Badui E, Valdespino A, Murillo H, et al: Trombólisis en trombosis protésica valvular mecánica. Manejo con estreptoquinasa. Arch Inst Cardiol Mex 1994; 64: 51-55.

  25. Vitale N, Rezulli A, Cerasoulo F, Caruso A, Festa M, De Luca L, et al: Prosthetic valve obstruction: Thrombolysis versus operation. Ann Thorac Surg 1994; 57: 365-370.

  26. Reddy NK, Padmanabhan TNC, Singh S, Kumar DN, Raju PR, Venkata - Satyanarayana P, et al: Thrombolysis in left-sided prosthetic valve occlusion: Immediate and follow-up results. Ann Thorac Surg 1994; 58: 462-471.

  27. Losi MA, Betocchi S, Briguori C, Manganelli F, Elia PP, Spampinato N, et al: Recombinant tissue-type plasminogen activator therapy in prosthetic mitral valve thrombosis: Assessment by transthoracic and transesophageal echocardiography. Int J Cardiol 1995; 48: 219-224.

  28. Astengo D, Badano L, Bertoli D: Recombinant tissue plasminogen activator for prosthetic mitral-valve thrombosis. N Engl J Med 1995; 333: 259–301.

  29. Hernandez VE, Stainback RF, Angelini P, Krajcer Z: Thrombolytic and left-sided prosthetic valve thrombosis. Tex Heart Inst J 1998; 25: 130-135.

  30. Manteiga R, Souto JC, Altes A, Mateo J, Aris A, Dominguez J, et al: Short-course thrombolysis as the first line of therapy for cardiac valve thrombosis. J Thorac Cardiovasc Surg 1998; 115: 780-784.

  31. Munclinger MJ, Patel JJ, Mitha AS: Thrombolysis of thrombosed St. Jude medical prosthetic valves: Rethrombosis -a sign of tissue in growth-. J Thorac Cardiovasc Surg 1998; 115: 248-249.

  32. Koca V, Bozat T, Sarikamis C, Akkaya V, Yavuz S, Ozdemir A: The use of transesophageal echocardiography guidance of thrombolytic therapy in prosthetic mitral valve thrombosis. J Heart Valve Dis 2000; 9: 374-378.

  33. Gupta D, Kothari SS, Bahl VK, Goswami KC, Talwar KK, Manchanda SC, et al: Thrombolytic therapy for prosthetic valve thrombosis: short and long-term results. Am Heart J 2000; 140: 906-916.

  34. Shapira Y, Herz I, Vaturi M, Porter A, Adler Y, Birnbaum Y, et al: Thrombolysis is an effective and safe therapy in struck bileaflet mitral valve in the absence of high-risk thrombi. J Am Coll Cardiol 2000; 35: 1874-1880.

  35. ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; 2: 349-360.

  36. ISIS-3 (Third International Study of Infarct Survival) Collaborative. ISIS-3: a randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin and heparin vs heparin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992; 339: 753-770.

  37. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.

  38. Goldhaber SA: Thrombolysis for pulmonary embolism. Prog Cardiovas Dis 1991; 2: 113-114.

  39. Jerjes-Sanchez C, Comparan Al, Ibarra M, Decanini H, Archondo T: Marcadores hemostáticos y de inflamación en síndromes coronarios agudos y su asociación con eventos cardiovasculares adversos. Arch Cardiol Mex 2006; 76: 366-375.

  40. Girard P, Stern JB, Parent F: Medical literature and vena cava filters. Chest 2002; 122: 963-967.

  41. Khot UM, Nissen SE: Is a CURE a cure for acute coronary syndromes? Statistical versus clinical significance. J Am Coll Cardiol 2002; 40: 218-219.

  42. Vandenbrouke JP: In defense of case reports and case series. Ann Intern Med 2001; 134: 330-334.

  43. Sanchez A, Cortadellas J, Figueras J, Gonzalez T, Soler J: Tratamiento fibirnolítico en pacientes con trombosis protésica y elevado riesgo quirúrgico. Rev Esp Cardiol 2001; 54: 1452-1455.

  44. Azpitarte J, Sanchez J, Urda T, Vivancos R, Oyonarte J, Malpartida F: Trombosis valvular protésica: ¿cuál es la terapia inicial más apropiada? Rev Esp Cardiol 2001; 54: 1367-1376.

  45. Kumar S, Grag N, Tewari S, Kapoor A, Goel P, Sinha N: Role of thrombolytic therapy for stuck prosthetic valves: A serial echocardiographic study. Indian Heart J 2001; 53: 551-7.

  46. Montorsi P, Cavoretto D, Alimento M, Muratori M, Pepi M: Prosthetic mitral valve thrombosis: can fluoroscopy predict the efficacy of thrombolytic treatment? Circulation 2003; 108: 79-84

  47. Ramos A, Ramos R, Togna D, Arnoni A, Staico R, Galo M, et al: Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results. Arq Bras Cardiol 2003; 81: 393-398.

  48. Shapira Y, Vaturi M, Hasdai D, Battler A, Saguie A: The safety and efficacy of repeated courses of tissue-type plasminogen activator in patients with stuck mitral valves who did not fully respond to the initial thrombolytic course. J Thromb and Haemost 2003; 1: 725-728.

  49. Roudaut R, Lafitte S, Roudaut M, Courtault C, Perron J, Jais C, et al: Fibrinolysis of mechanical prosthetic valve thrombosis a single-center study of 127 Cases. J Am Coll Cardiol 2003; 41: 653-658.

  50. Tong T, Roudaut R, Özkan M, Sagie A, Shahid M, Pontes S, et al: Transesophageal echocardiography improves risk assessment of thrombolysis of prosthetic valve thrombosis: results of the international PRO-TEE Registry. J Am Coll Cardiol 2004; 43: 77-84.

  51. Balasundaram R, Karthikeyan G, Kothari S, Talwar K, Venugopal P: Fibrinolytic treatment for recurrent left sided prosthetic valve thrombosis. Heart 2005; 91: 921-922.

  52. Caceres F, Perez H, Morlans K, Facundo H, Santos J, Valiente J, et al: Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients. J Thromb Thrombolysis 2006; 21: 185-190.

  53. Koller PT, Arom KV: Thrombolytic therapy of left side prosthetic valve thrombosis. Chest 1995; 108: 1683–1689.




2020     |     www.medigraphic.com